Investor Relations

Press Releases

 
Press Releases
  Date Title View
Apr 28, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D. has stepped down as the company's President and Co-Chief Executive Officer and David Zaccardelli, Pharm.D. has stepped down as the company's Executive Vice President and Chief Ope...
Apr 28, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2016. "Our total revenues increased as compared to the same period in the prior year, which shows that our medicines are continuing to r...
Apr 27, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 27, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, of United Therapeutics will provide an overview and update on the company's business at the Deutsche Bank 41st Annual Health Care C...
Apr 20, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 20, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2016 financial results before market open on Thursday, April 28, 2016. United Therapeutics will host a half-hour teleconference on Thursday, April 28, 2016, ...
Mar 8, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 8, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Barclays Global Healthcare Conference in Miam...
Feb 25, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2015. "We are pleased with our 2015 top-line financial results as fourth-quarter revenues were $405 million, a 17% increase,...
Feb 18, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2015 financial results before market open on Thursday, February 25, 2016. United Therapeutics will host a half-hour teleconference on Thursday, Fe...
Feb 18, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced receipt of a Paragraph IV Certification Notice Letter on February 18, 2016 from Actavis Laboratories FL, Inc. (Actavis) advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S....
Jan 6, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United Therapeutics will provide an overview and update on the company's business at the 34th Annual J.P. Morgan Healthcare Conference ...
Oct 27, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2015. "We are pleased with our third quarter 2015 results as total revenues reached $386 million and each of our pulmonary arterial h...
1
... NextLast
= add release to Briefcase